These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2143613)

  • 1. [The OF characteristics of streptococci group A and immunity to streptococcal infection based on the results of OF and anti-OF tests].
    Krasil'nikov IA; Iontova IM; Beliakova IV; Sobolevskaia AA; Zubov AK; Stepanova TM; Fomina NI; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):26-31. PubMed ID: 2143613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation ratio and T- serotyping of group A streptococci from pediatric upper respiratory tract infections in Turkey.
    Topkaya AE; Yildirim T; Arsan S
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):302-4. PubMed ID: 16330397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to streptococcal opacity factor in a selected Indian population.
    Prakash K; Dutta S
    J Med Microbiol; 1991 Feb; 34(2):119-24. PubMed ID: 1990141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of streptococcal proteinase in acute post-streptococcal glomerulonephritis.
    Cu GA; Mezzano S; Zabriskie JB
    Adv Exp Med Biol; 1997; 418():137-40. PubMed ID: 9331617
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characteristics on the onset features of scarlet fever in Beijing, 2006-2015].
    Wu SS; Ma CN; Peng XM; Zhang DT; Wang QY; Yang P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):514-517. PubMed ID: 28468073
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of beta-hemolytic streptococci secreted in children in various climatic zones].
    Gladkova KK; Cherkasskaia RS; Dodonov VN; Severov AM; Silich VA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Dec; (12):71-4. PubMed ID: 130040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Group A streptococci isolated from patients with infectious diseases in the surveillance system of pathogenic microbes in Akita and their serotypes].
    Morita M; Kon T; Shoji K; Motegi T; Takayama K; Yamawaki T; Saito S; Fujimiya Y; Shibata Y; Okamura T
    Kansenshogaku Zasshi; 1987 Apr; 61(4):537-44. PubMed ID: 3117941
    [No Abstract]   [Full Text] [Related]  

  • 8. [Toxigenic hemolytic streptococci isolated from patients with scarlatina and those having contact with them].
    Cherkasskaia RS; Dodonov VN; Silich VA; Gladkova KK; Fiks LI
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):67-72. PubMed ID: 4273361
    [No Abstract]   [Full Text] [Related]  

  • 9. [Virulent and toxigenic properties of beta-hemolytic streptococci in relation to the scarlatina epidemic process].
    Gladkova KK; Dodonov VN; Bliumental' KV; Cherkasskaia RS; Severov AM
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jul; 50(7):24-7. PubMed ID: 4272990
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology of group A streptococcal infections--their changing frequency and severity.
    Quinn RW
    Yale J Biol Med; 1982; 55(3-4):265-70. PubMed ID: 6758372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The production of pyrogenic exotoxins by group A streptococci.
    Hallas G
    J Hyg (Lond); 1985 Aug; 95(1):47-57. PubMed ID: 3926872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological usefulness of anti-opacity factor antibody screening in schoolchildren.
    Kim S; Lee NY
    J Clin Microbiol; 2001 Apr; 39(4):1316-8. PubMed ID: 11283048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Types and virulence of hemolytic streptococci isolated from scarlet fever patients].
    Gladkova KK; Strel'tsova NA; Cherkasskaia RS; Kaminskaia EI; Fiks LI
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Jan; 47(1):123-6. PubMed ID: 4915136
    [No Abstract]   [Full Text] [Related]  

  • 14. Outbreaks of group A beta-hemolytic streptococcal pharyngitis in children: correlation of serotype T4 with scarlet fever.
    Ohga S; Okada K; Mitsui K; Aoki T; Ueda K
    Scand J Infect Dis; 1992; 24(5):599-605. PubMed ID: 1465577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dynamics of detecting group-A streptococci in an infectious disease clinic].
    Pavlova EB; Iontova IM; Bystriakova LV
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):16-9. PubMed ID: 1301653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Streptococcal group A carriage: new data on the characteristics of the biology of the causative agent and of the immune response of the host].
    Briko NI; Dmitrieva NF; Eshchina AS; Dynga LO; Shevelev BI; Sobolev VI; Vylegzhanina ES; Kuksiuk PP
    Zh Mikrobiol Epidemiol Immunobiol; 1994; Suppl 1():51-5. PubMed ID: 7856351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating serotypes and antimicrobial sensitivity of Streptococcus pyogenes isolates from children in Cyprus.
    Koliou M; Ioannou Y; Efstratiou A; Hannidou N; Pieri V; Alexandrou M; Soteriades ES
    Clin Microbiol Infect; 2007 Jun; 13(6):645-7. PubMed ID: 17378928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type distribution of Streptococcus pyogenes in the years 1964-65 and 1968-69.
    Szita J; Káli M
    Acta Microbiol Acad Sci Hung; 1970; 17(4):347-56. PubMed ID: 4935612
    [No Abstract]   [Full Text] [Related]  

  • 19. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
    Pandey M; Mortensen R; Calcutt A; Powell J; Batzloff MR; Dietrich J; Good MF
    J Immunol; 2016 Apr; 196(8):3364-74. PubMed ID: 26969753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.
    Courtney HS; Hasty DL; Dale JB
    Infect Immun; 2003 Sep; 71(9):5097-103. PubMed ID: 12933852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.